CD274 and non-small cell lung carcinoma: Ubiquitin‐conjugating enzyme E2 variant 2 (UBE2V2) shows a positive correlation with PD‐L1 expression in NSCLC lung adenocarcinomas, suggesting poor efficacy of immune checkpoint inhibitors and susceptibility to resistance [51].